Article Details

Kiromic BioPharma Reports Second Quarter 2021 Financial Results and Operating Highlights

Retrieved on: 2021-08-13 19:07:30

Tags for this article:

Click the tags to see associated articles and topics

Kiromic BioPharma Reports Second Quarter 2021 Financial Results and Operating Highlights. View article details on hiswai:

Excerpt

IND Applications. Clinical Trials Updates. — ALEXIS-PRO-1: Off-the-Shelf, Allogenic CAR-T expressing chPD1 for Solid Tumors (IV admin.).

Article found on: www.bollyinside.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up